Study on Preliminary Safety and Efficacy of Epidural Electrical Stimulation to Manage Lower Urinary Tract Dysfunction After Spinal Cord Injury
A legfontosabb adatok
- Ki végzi
- Ecole Polytechnique Fédérale de Lausanne
- Hol
- Lausanne (Svájc)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 3 fő, tervezett
- Kezdés
- 2025. márc. 10.
- Várható befejezés
- 2027. febr.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- WaveWriter Alpha™ neurostimulation system
- A regiszteradat frissítve
- 2026. szeptember 16.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with a spinal cord injury for at least 6 months who have bladder problems. They will test a device that sends electrical pulses to the spinal cord.
- Életkor
- 18 Years or older
- Nem
- All
- A betegség stádiuma
- Spinal cord injury at level T11 or higher (T11 included), graded AIS B, C or D, present for 6 months or more. Bladder problems (NDO, DSD) confirmed by a bladder pressure test (urodynamic test).
- Korábbi kezelés
- Medicines and behaviour changes for the bladder did not work or were not tolerated. Must use self-catheterization from time to time. Cannot join after botulinum toxin bladder injections in the previous 6 months, or with previous lower urinary tract surgery.
A részvétel fő kizáró okai
- Needs or has a permanent bladder catheter, or uses other non-drug bladder treatment such as sacral nerve stimulation
- Swelling of the upper urinary tract, bladder or kidney stones, or more than 3 urinary infections per year
- Heart pacemaker, intrathecal baclofen pump, or a need for MRI scans
- Health problems that make spinal surgery more risky, or serious other diseases
- Pregnant, breastfeeding, or planning a pregnancy
A regiszter feltételei, szó szerint
Mind a 33 feltétel megnézéseKevesebb
Ki vehet részt
- Age 18 or older
- Must provide and sign the Informed Consent Form prior to any study-related procedures
- Spinal cord injury lesion level above T11 (inclusive)
- SCI graded as AIS- B, C or D
- SCI ≥ 6 months
- Confirmed lower urinary tract dysfunction during urodynamic assessment (NDO, DSD)
- Intolerant, refractory or inefficient to conservative treatment options such as medications and behavioural management
- Using intermittent self-catheterization
- Stable medical, physical and psychological condition as considered by the investigators
- Able to understand and interact with the study team in French or English
- Agrees to comply in good faith with all conditions of the study and to attend all scheduled appointments
Ki nem vehet részt
- Botulinum toxin vesical injections in the previous 6 months
- Previous lower urinary tract surgery
- Other clinically significant concomitant disease states (e.g., syringomyelia, bladder cancer, renal failure, hepatic dysfunction, cardiovascular disease, etc.)
- Participation in another study with investigational drug or device within the 30 days preceding and during the present study
- Recurrent and symptomatic urinary tract infection (more than 3 per year)
- Diseases and conditions that would increase the morbidity and mortality of spinal surgery
- Presence of pacemakers for cardiac conditions
- Other conditions that would make the subject unable to participate in testing in the judgement of the investigators
- Inability to follow the procedures of the study, e.g. due to language problems, mental illness, psychological disorders, or dementia of the participant
- Presence of non-pharmacological treatments for lower urinary tract dysfunction (e.g. sacral nerve stimulation)
- Does have or needs a suprapubic catheter or bladder indwelling catheter
- Presence of upper urinary tract dilatation or bladder or renal stones
- Presence of urethral stricture or significant benign prostate hyperplasia
- Presence of significant pressure ulcers
- Presence of Autonomic Dysreflexia during urodynamic test
- Presence of intrathecal baclofen pump
- The inability to withhold antiplatelet/anticoagulation agents perioperatively
- Women who are pregnant (pregnancy test obligatory for woman of childbearing potential) or breast feeding
- Lack of acceptable or highly effective method of contraception for women of childbearing capacity
- Intention to become pregnant during the course of the study
- Have any indication that would require Magnetic Resonance Imaging (MRI)
- Is the investigator himself, his/her family members, employees or other dependent persons
Helyszínek itt: Svájc
- Centre Hospitalier Universitaire Vaudois (CHUV)Lausanne, SvájcContact: Jocelyne Bloch, Prof. Dr.Résztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
This clinical trial aims to assess the preliminary safety and efficacy of Epidural Electrical Stimulation (EES) therapy in managing lower urinary tract dysfunction in individuals with sub-acute or chronic spinal cord injury (SCI). The study evaluates the therapy's potential to improve urinary function and prevent neurogenic detrusor overactivity, ultimately seeking to enhance quality of life for individuals with SCI.
A vizsgálat csoportja
- All participantsA vizsgált kezelés
All participants enrolled in the study will receive the same intervention. This clinical trial evaluates a novel therapy using a CE-marked medical device employed off-label. Participants will undergo implantation of a neurostimulation system designed to deliver electrical stimulation to the spinal cord. The therapy aims to improve control over detrusor and urethral sphincter muscles by targeting the associated nerves.
Kezelés: WaveWriter Alpha™ neurostimulation system
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2026. szeptember 16.